These findings are biologically plausible considering that the mechanism of action of these drugs does not lead to greater insulin secretion—for example, the mode of action of thiazolidinediones as insulin sensitizers28 means that they are unlikely to benefit individuals if insulin deficiency is underpinning hyperglycemia. Here, INS is linked to Hyperglycemia.